Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 34.08 | N/A |
| PEG Ratio (TTM) | -52.49 | N/A |
| P/S Ratio (TTM) | 2.95 | N/A |
| P/B Ratio (TTM) | 1.31 | N/A |
| P/FCF Ratio (TTM) | 32.90 | N/A |
| Price to 5YR AVG Earnings Ratio | 16.46 | N/A |
| Price to 5YR AVG FCF Ratio | 15.18 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.36% | N/A |
| ROE (TTM) | 3.88% | N/A |
| Net Profit Margin (TTM) | 8.60% | N/A |
| ROIC 5YR AVG | 68.06% | N/A |
Growth (58%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3.63% | 9.18% | 2.96% |
| Revenue | -7.65% | 5.31% | 9.98% |
| Net Income | 3.90% | 10.38% | 2.36% |
| Cash Flow | 11.40% | 1,314.49% | 772.94% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.39 | N/A |
| Quick Ratio (TTM) | 0.39 | N/A |
| D/E Ratio (TTM) | 0.51 | N/A |
| Interest Coverage (TTM) | 0.74 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 0.01 | N/A |
| LTL to 5YR AVG FCF | 4.67 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.90% | N/A |